Alector Newsroom

Alector Analyst Ratings

BenzingaJun 20 06:20 ET

Barclays Sticks to Their Buy Rating for Alector (ALEC)

TipRanksMay 10 06:16 ET

Alector Analyst Ratings

BenzingaMay 9 10:31 ET

Analysts Offer Insights on Healthcare Companies: DocGo (DCGO), Revance Therapeutics (RVNC) and Alector (ALEC)

TipRanksFeb 29 06:40 ET

Optimistic Buy Rating for Alector's AL002 Based on Promising Alzheimer's Disease Trial Biomarkers and TREM2 Signaling Efficacy

TipRanksFeb 28 07:38 ET

Alector: Cautious Hold Rating Ahead of Key Clinical Trial Milestones and Financial Assessment

TipRanksFeb 28 05:37 ET

Alector (ALEC) Receives a Buy From Barclays

TipRanksFeb 28 03:37 ET

TD Cowen Sticks to Their Buy Rating for Alector (ALEC)

TipRanksFeb 27 19:05 ET

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Alector (ALEC) and Cytokinetics (CYTK)

TipRanksFeb 13 05:27 ET

Alector's Promising Pipeline and Market Potential Affirm Buy Rating

TipRanksFeb 13 05:23 ET

Analysts Offer Insights on Healthcare Companies: Alector (ALEC), Viking Therapeutics (VKTX) and Zimmer Biomet Holdings (ZBH)

TipRanksFeb 8 20:01 ET

Alector (ALEC) Gets a Buy From BTIG

TipRanksJan 7 05:27 ET

A Buy Rating for Alector: Innovating in Neurodegeneration With a Promising Immuno-Neurology Pipeline

TipRanksDec 19, 2023 02:36 ET

Stifel Upgrades Alector to Buy, Stock Rallies 18%

Seeking AlphaDec 14, 2023 15:01 ET

Stifel Upgrades Alector to Buy, Raises Price Target to $15

BenzingaDec 14, 2023 05:02 ET

Alector Analyst Ratings

BenzingaDec 14, 2023 05:00 ET

Alector Analyst Ratings

BenzingaDec 12, 2023 04:54 ET

Mizuho Maintains Buy on Alector, Lowers Price Target to $9

BenzingaNov 17, 2023 12:28 ET

Alector Analyst Ratings

BenzingaNov 17, 2023 12:27 ET

Mizuho Securities Trims Price Target on Alector to $9 From $10, Keeps Buy Rating

MT NewswiresNov 16, 2023 07:42 ET